Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury.
薬物誘発性肝障害の関連リスク評価
対象DB：VigiBase
Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System.
グルカゴン様ペプチド-1（GLP-1）受容体作動薬と網膜有害事象との関連性評価
対象DB：FAERS
Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.
スタチン使用に関連する筋萎縮性側索硬化症（ALS）様症状関連性評価
対象DB：FAERS